News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

An illustration of a smartphone with a butternut squash yellow screen which is surrounded by small green and yellow illustrations, including a black megaphone
News Release

A new AI model predicts which short-form videos triggering suicidal thoughts in vulnerable viewers pose higher risk before they reach large audiences, which can improve user safety.

Read More
A thumb hovers over a cell phone screen lit up with square icons, specifically the white and black ChatGPT
News Release

While generative AI (GenAI) can help define viable objectives for organizational and policy decision-making, the overall quality of those objectives falls short unless humans intervene.

Read More
Many megaphones of different colors facing every direction hover over a lined purple floor.
News Release

A new study finds that social media marketing does little to help high-quality firms stand apart from competitors. Instead, it often pushes companies of all quality levels toward similar spending and pricing strategies, blurring the very signals firms hope will differentiate them in digital marketplaces.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
Gov. Kemp to give update on COVID-19

Gov. Kemp to give update on COVID-19

WGXA-TV, March 16, 2021

Gov. Brian Kemp is set to give an update on distributing the coronavirus vaccine in Georgia. Kemp and other state leaders are scheduled to speak starting at 4 p.m. from the State Capitol.

How do mRNA vaccines work - and why do you need a second dose? 5 essential reads

How do mRNA vaccines work - and why do you need a second dose? 5 essential reads

The Telegraph, March 16, 2021

Tens of millions of people across the U.S. have received a coronavirus vaccine. So far, the majority of doses have been either the Moderna or Pfizer vaccine, both of which use mRNA to generate an immune response. These gene-based vaccines have been in the works for decades, but this is the first time they have been used widely in people.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine